Bruce Kramer believed that researchers need to rethink the way they test new drugs on ALS patients like him.
He argued that the double-blind testing model doesn't work for a devastating fatal illness like ALS.
In this episode of Living While Dying, we also hear from a bio-ethicist about the decision to deny some patients access to an experimental drug.
Grow the Future of Public Media
MPR News is supported by Members. Gifts from individuals power everything you find here. Make a gift of any amount today to become a Member!